Friday, June 21, 2013

Reuters: Health News: UK cost agency turns down Sanofi bowel cancer drug

UK cost agency turns down Sanofi bowel cancer drug

LONDON (Reuters) - Sanofi's new bowel cancer drug Zaltrap is not worth using on Britain's state health service given its high price, the country's hea...

Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/Uq_qukhYQ7k/story01.htm


No comments:

Post a Comment

Subscribe Now: Feed Icon